- Status:
- Red
- Decision Date:
- June 2022
Comments
RED: NICE HST20 - Selumetinib for treating symptomatic and inoperable plexiform
neurofibromas associated with type 1 neurofibromatosis in children aged 3 and
over
Red Drug Classifications
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again